LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: Author Correction: Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.

    Rosenthal, Philip J / Asua, Victor / Conrad, Melissa D

    Nature reviews. Microbiology

    2024  

    Language English
    Publishing date 2024-02-27
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2139054-X
    ISSN 1740-1534 ; 1740-1526
    ISSN (online) 1740-1534
    ISSN 1740-1526
    DOI 10.1038/s41579-024-01032-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.

    Rosenthal, Philip J / Asua, Victor / Conrad, Melissa D

    Nature reviews. Microbiology

    2024  

    Abstract: Malaria, mostly due to Plasmodium falciparum infection in Africa, remains one of the most important infectious diseases in the world. Standard treatment for uncomplicated P. falciparum malaria is artemisinin-based combination therapy (ACT), which ... ...

    Abstract Malaria, mostly due to Plasmodium falciparum infection in Africa, remains one of the most important infectious diseases in the world. Standard treatment for uncomplicated P. falciparum malaria is artemisinin-based combination therapy (ACT), which includes a rapid-acting artemisinin derivative plus a longer-acting partner drug, and standard therapy for severe P. falciparum malaria is intravenous artesunate. The efficacy of artemisinins and ACT has been threatened by the emergence of artemisinin partial resistance in Southeast Asia, mediated principally by mutations in the P. falciparum Kelch 13 (K13) protein. High ACT treatment failure rates have occurred when resistance to partner drugs is also seen. Recently, artemisinin partial resistance has emerged in Rwanda, Uganda and the Horn of Africa, with independent emergences of different K13 mutants in each region. In this Review, we summarize our current knowledge of artemisinin partial resistance and focus on the emergence of resistance in Africa, including its epidemiology, transmission dynamics and mechanisms. At present, the clinical impact of emerging resistance in Africa is unclear and most available evidence suggests that the efficacies of leading ACTs remain excellent, but there is an urgent need to better appreciate the extent of the problem and its consequences for the treatment and control of malaria.
    Language English
    Publishing date 2024-02-06
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2139054-X
    ISSN 1740-1534 ; 1740-1526
    ISSN (online) 1740-1534
    ISSN 1740-1526
    DOI 10.1038/s41579-024-01008-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East Asia.

    Meier-Scherling, Cecile P G / Watson, Oliver J / Asua, Victor / Ghinai, Isaac / Katairo, Thomas / Garg, Shreeya / Conrad, Melissa / Rosenthal, Philip J / Okell, Lucy C / Bailey, Jeffrey A

    medRxiv : the preprint server for health sciences

    2024  

    Abstract: Background: Artemisinin partial resistance, mediated by mutations in the : Methods: We investigated K13 mutation prevalence at 16 sites in Uganda (2016-2022, 6586 samples), and five sites in SEA (2003-2018, 5465 samples) by calculating selection ... ...

    Abstract Background: Artemisinin partial resistance, mediated by mutations in the
    Methods: We investigated K13 mutation prevalence at 16 sites in Uganda (2016-2022, 6586 samples), and five sites in SEA (2003-2018, 5465 samples) by calculating selection coefficients using Bayesian mixed-effect linear models. We then tested whether SEA K13 mutation prevalence could have been forecast accurately using up to the first five years of available data and forecast future K13 mutation prevalence in Uganda.
    Findings: The selection coefficient for the prevalence of relevant K13 mutations (441L, 469F/Y, 561H, 675V) was estimated at s=0·383 (95% CrI: 0·247 - 0·528) per year, a 38% relative prevalence increase. Selection coefficients across Uganda were s=0·968 (0·463 - 1·569) for 441L, s=0·153 (-0·445 - 0·727) for 469F, s=0·222 (-0·011 - 0·398) for 469Y, and s=0·152 (-0·023 - 0·312) for 675V. In SEA, the selection coefficient was s=-0·005 (-0·852 - 0·814) for 539T, s=0·574 (-0·092 - 1·201) for 580Y, and s=0·308 (0·089 - 0·536) for all validated K13 mutations. Forecast prevalences for Uganda assuming constant selection neared fixation (>95% prevalence) within a decade (2028-2033) for combined K13 mutations.
    Interpretation: The selection of K13 mutations in Uganda was at a comparable rate to that observed in SEA, suggesting K13 mutations may continue to increase quickly in Uganda.
    Funding: NIH R01AI156267, R01AI075045, and R01AI089674.
    Language English
    Publishing date 2024-02-04
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.02.03.24302209
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The emergence of artemisinin partial resistance in Africa: how do we respond?

    Rosenthal, Philip J / Asua, Victor / Bailey, Jeffrey A / Conrad, Melissa D / Ishengoma, Deus S / Kamya, Moses R / Rasmussen, Charlotte / Tadesse, Fitsum G / Uwimana, Aline / Fidock, David A

    The Lancet. Infectious diseases

    2024  

    Abstract: Malaria remains one of the most important infectious diseases in the world, with the greatest burden in sub-Saharan Africa, primarily from Plasmodium falciparum infection. The treatment and control of malaria is challenged by resistance to most available ...

    Abstract Malaria remains one of the most important infectious diseases in the world, with the greatest burden in sub-Saharan Africa, primarily from Plasmodium falciparum infection. The treatment and control of malaria is challenged by resistance to most available drugs, but partial resistance to artemisinins (ART-R), the most important class for the treatment of malaria, was until recently confined to southeast Asia. This situation has changed, with the emergence of ART-R in multiple countries in eastern Africa. ART-R is mediated primarily by single point mutations in the P falciparum kelch13 protein, with several mutations present in African parasites that are now validated resistance mediators based on clinical and laboratory criteria. Major priorities at present are the expansion of genomic surveillance for ART-R mutations across the continent, more frequent testing of the efficacies of artemisinin-based regimens against uncomplicated and severe malaria in trials, more regular assessment of ex-vivo antimalarial drug susceptibilities, consideration of changes in treatment policy to deter the spread of ART-R, and accelerated development of new antimalarial regimens to overcome the impacts of ART-R. The emergence of ART-R in Africa is an urgent concern, and it is essential that we increase efforts to characterise its spread and mitigate its impact.
    Language English
    Publishing date 2024-03-26
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(24)00141-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Comparative Analysis of Plasmodium falciparum Genotyping via SNP Detection, Microsatellite Profiling, and Whole-Genome Sequencing.

    Kanai, Mariko / Yeo, Tomas / Asua, Victor / Rosenthal, Philip J / Fidock, David A / Mok, Sachel

    Antimicrobial agents and chemotherapy

    2021  Volume 66, Issue 1, Page(s) e0116321

    Abstract: Research efforts to combat antimalarial drug resistance rely on quick, robust, and sensitive methods to genetically characterize Plasmodium falciparum parasites. We developed a single-nucleotide polymorphism (SNP)-based genotyping method that can assess ... ...

    Abstract Research efforts to combat antimalarial drug resistance rely on quick, robust, and sensitive methods to genetically characterize Plasmodium falciparum parasites. We developed a single-nucleotide polymorphism (SNP)-based genotyping method that can assess 33 drug resistance-conferring SNPs in
    MeSH term(s) Antimalarials/pharmacology ; Antimalarials/therapeutic use ; Drug Resistance/genetics ; Genotype ; Humans ; Malaria, Falciparum/parasitology ; Microsatellite Repeats/genetics ; Plasmodium falciparum/genetics ; Protozoan Proteins/genetics
    Chemical Substances Antimalarials ; Protozoan Proteins
    Language English
    Publishing date 2021-10-25
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/AAC.01163-21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda.

    Conrad, Melissa D / Asua, Victor / Garg, Shreeya / Giesbrecht, David / Niaré, Karamoko / Smith, Sawyer / Namuganga, Jane F / Katairo, Thomas / Legac, Jennifer / Crudale, Rebecca M / Tumwebaze, Patrick K / Nsobya, Samuel L / Cooper, Roland A / Kamya, Moses R / Dorsey, Grant / Bailey, Jeffrey A / Rosenthal, Philip J

    The New England journal of medicine

    2023  Volume 389, Issue 8, Page(s) 722–732

    Abstract: Background: Partial resistance of : Methods: We performed annual surveillance among patients who presented with uncomplicated malaria at 10 to 16 sites across Uganda from 2016 through 2022. We sequenced the gene encoding kelch 13 (: Results: By ... ...

    Abstract Background: Partial resistance of
    Methods: We performed annual surveillance among patients who presented with uncomplicated malaria at 10 to 16 sites across Uganda from 2016 through 2022. We sequenced the gene encoding kelch 13 (
    Results: By 2021-2022, the prevalence of parasites with validated or candidate resistance markers reached more than 20% in 11 of the 16 districts where surveillance was conducted. The PfK13 469Y and 675V mutations were seen in far northern Uganda in 2016-2017 and increased and spread thereafter, reaching a combined prevalence of 10 to 54% across much of northern Uganda, with spread to other regions. The 469F mutation reached a prevalence of 38 to 40% in one district in southwestern Uganda in 2021-2022. The 561H mutation, previously described in Rwanda, was first seen in southwestern Uganda in 2021, reaching a prevalence of 23% by 2022. The 441L mutation reached a prevalence of 12 to 23% in three districts in western Uganda in 2022. Genetic analysis indicated local emergence of mutant parasites independent of those in Southeast Asia. The emergence of resistance was observed predominantly in areas where effective malaria control had been discontinued or transmission was unstable.
    Conclusions: Data from Uganda showed the emergence of partial resistance to artemisinins in multiple geographic locations, with increasing prevalence and regional spread over time. (Funded by the National Institutes of Health.).
    MeSH term(s) Animals ; Humans ; Artemisinins/pharmacology ; Artemisinins/therapeutic use ; Benchmarking ; Parasites/drug effects ; Parasites/genetics ; Uganda/epidemiology ; Drug Resistance/genetics ; Malaria/drug therapy ; Malaria/genetics ; Malaria/parasitology ; Protozoan Proteins/genetics
    Chemical Substances artemisinin (9RMU91N5K2) ; Artemisinins ; Protozoan Proteins
    Language English
    Publishing date 2023-08-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMoa2211803
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Associations between Aminoquinoline Resistance Genotypes and Clinical Presentations of Plasmodium falciparum Infection in Uganda.

    Cuu, Gloria / Asua, Victor / Tukwasibwe, Stephen / Nsobya, Sam L / Nanteza, Ann / Kimuda, Magambo Phillip / Mpimbaza, Arthur / Rosenthal, Philip J

    Antimicrobial agents and chemotherapy

    2020  Volume 64, Issue 10

    Abstract: Mutations that mediate resistance ... ...

    Abstract Mutations that mediate resistance of
    MeSH term(s) Aminoquinolines/therapeutic use ; Antimalarials/therapeutic use ; Case-Control Studies ; Child ; Child, Preschool ; Drug Resistance ; Genotype ; Humans ; Infant ; Malaria, Falciparum/drug therapy ; Multidrug Resistance-Associated Proteins/genetics ; Plasmodium falciparum/genetics ; Protozoan Proteins/genetics ; Uganda
    Chemical Substances Aminoquinolines ; Antimalarials ; Multidrug Resistance-Associated Proteins ; Protozoan Proteins
    Language English
    Publishing date 2020-09-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/AAC.00721-20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Associations between erythrocyte polymorphisms and risks of uncomplicated and severe malaria in Ugandan children: A case control study.

    Mpimbaza, Arthur / Walakira, Andrew / Ndeezi, Grace / Katahoire, Anne / Karamagi, Charles / Nsobya, Samuel L / Tukwasibwe, Stephen / Asua, Victor / Rosenthal, Philip J

    PloS one

    2018  Volume 13, Issue 9, Page(s) e0203229

    Abstract: Background: Evidence for association between sickle cell and alpha thalassemia trait and severe malaria is compelling. However, for these polymorphisms associations with uncomplicated malaria, and for G6PD deficiency associations with uncomplicated and ... ...

    Abstract Background: Evidence for association between sickle cell and alpha thalassemia trait and severe malaria is compelling. However, for these polymorphisms associations with uncomplicated malaria, and for G6PD deficiency associations with uncomplicated and severe malaria, findings have been inconsistent. We studied samples from a three-arm case-control study with the objective of determining associations between common host erythrocyte polymorphisms and both uncomplicated and severe malaria, including different severe malaria phenotypes.
    Method: We assessed hemoglobin abnormalities, α-thalassemia, and G6PD deficiency by molecular methods in 325 children with severe malaria age-matched to 325 children with uncomplicated malaria and 325 healthy community controls. Conditional logistic regression was used to measure associations between specified genotypes and malaria outcomes.
    Results: No tested polymorphisms offered significant protection against uncomplicated malaria. α-thalassemia homozygotes (_α/_α) had increased risk of uncomplicated malaria (OR 2.40; 95%CI 1.15, 5.03, p = 0.020). HbAS and α-thalassemia heterozygous (_α/αα) genotypes protected against severe malaria compared to uncomplicated malaria (HbAS OR 0.46; 0.23, 0.95, p = 0.036; _α/αα OR 0.51; 0.24, 0.77; p = 0.001) or community (HbAS OR 0.23; 0.11, 0.50; p<0.001; _α/αα; OR 0.49; 0.32, 0.76; p = 0.002) controls. The α-thalassemia homozygous (_α/_α) genotype protected against severe malaria when compared to uncomplicated malaria controls (OR 0.34; 95%CI 0.156, 0.73, p = 0.005), but not community controls (OR 1.03; 0.46, 2.27, p = 0.935). Stratifying by the severe malaria phenotype, compared to community controls, the protective effect of HbAS was limited to children with severe anemia (OR 0.17; 95%CI 0.04, 0.65; p = 0.009) and that of _α/αα to those with altered consciousness (OR 0.24; 0.09, 0.59; p = 0.002). A negative epistatic effect was seen between HbAS and _α/αα; protection compared to uncomplicated malaria controls was not seen in individuals with both polymorphisms (OR 0.45; 0.11, 1.84; p = 0.269). G6PD deficiency was not protective against severe malaria.
    Conclusion: Associations were complex, with HbAS principally protective against severe anemia, _α/αα against altered consciousness, and negative epistasis between the two polymorphisms.
    MeSH term(s) Case-Control Studies ; Child ; Child, Preschool ; Erythrocytes/metabolism ; Erythrocytes/pathology ; Female ; Genotype ; Glucosephosphate Dehydrogenase Deficiency/blood ; Glucosephosphate Dehydrogenase Deficiency/complications ; Glucosephosphate Dehydrogenase Deficiency/genetics ; Hemoglobins, Abnormal/genetics ; Humans ; Infant ; Malaria/blood ; Malaria/complications ; Malaria/genetics ; Male ; Phenotype ; Polymorphism, Genetic ; Risk Factors ; Sickle Cell Trait/blood ; Sickle Cell Trait/complications ; Sickle Cell Trait/genetics ; Uganda ; alpha-Thalassemia/blood ; alpha-Thalassemia/complications ; alpha-Thalassemia/genetics
    Chemical Substances Hemoglobins, Abnormal
    Language English
    Publishing date 2018-09-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0203229
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Associations between Malaria-Preventive Regimens and Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Ugandan Pregnant Women.

    Nayebare, Patience / Asua, Victor / Conrad, Melissa D / Kajubi, Richard / Kakuru, Abel / Nankabirwa, Joaniter I / Muhanguzi, Dennis / Dorsey, Grant / Kamya, Moses R / Nsobya, Sam / Rosenthal, Philip J

    Antimicrobial agents and chemotherapy

    2020  Volume 64, Issue 12

    Abstract: Intermittent preventive treatment in pregnancy (IPTp) with monthly sulfadoxine-pyrimethamine (SP) is recommended for malaria-endemic parts of Africa, but efficacy is compromised by resistance, and, in recent trials, dihydroartemisinin-piperaquine (DP) ... ...

    Abstract Intermittent preventive treatment in pregnancy (IPTp) with monthly sulfadoxine-pyrimethamine (SP) is recommended for malaria-endemic parts of Africa, but efficacy is compromised by resistance, and, in recent trials, dihydroartemisinin-piperaquine (DP) has shown better antimalarial protective efficacy. We utilized blood samples from a recent trial to evaluate selection by IPTp with DP or SP of
    MeSH term(s) Antimalarials/pharmacology ; Antimalarials/therapeutic use ; Drug Combinations ; Drug Resistance/drug effects ; Drug Resistance/genetics ; Female ; Humans ; Malaria/drug therapy ; Malaria, Falciparum/drug therapy ; Malaria, Falciparum/genetics ; Malaria, Falciparum/prevention & control ; Plasmodium falciparum/drug effects ; Plasmodium falciparum/genetics ; Polymorphism, Genetic/drug effects ; Polymorphism, Genetic/genetics ; Pregnancy ; Pregnant Women ; Pyrimethamine/therapeutic use ; Sulfadoxine/therapeutic use ; Uganda
    Chemical Substances Antimalarials ; Drug Combinations ; Sulfadoxine (88463U4SM5) ; Pyrimethamine (Z3614QOX8W)
    Language English
    Publishing date 2020-11-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/AAC.01047-20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Drug susceptibility of

    Tumwebaze, Patrick K / Katairo, Thomas / Okitwi, Martin / Byaruhanga, Oswald / Orena, Stephen / Asua, Victor / Duvalsaint, Marvin / Legac, Jennifer / Chelebieva, Sevil / Ceja, Frida G / Rasmussen, Stephanie A / Conrad, Melissa D / Nsobya, Samuel L / Aydemir, Ozkan / Bailey, Jeffrey A / Bayles, Brett R / Rosenthal, Philip J / Cooper, Roland A

    The Lancet. Microbe

    2021  Volume 2, Issue 9, Page(s) e441–e449

    Abstract: Background: Treatment and control of malaria depends on artemisinin-based combination therapies (ACTs) and is challenged by drug resistance, but thus far resistance to artemisinins and partner drugs has primarily occurred in southeast Asia. The aim of ... ...

    Abstract Background: Treatment and control of malaria depends on artemisinin-based combination therapies (ACTs) and is challenged by drug resistance, but thus far resistance to artemisinins and partner drugs has primarily occurred in southeast Asia. The aim of this study was to characterise antimalarial drug susceptibility of
    Methods: In this prospective longitudinal study,
    Findings: From June 10, 2016, to July 29, 2019, 361
    Interpretation: Our results show marked changes in
    Funding: National Institutes of Health and Medicines for Malaria Venture.
    MeSH term(s) Antimalarials/pharmacology ; Chloroquine/pharmacology ; Genotype ; Humans ; Longitudinal Studies ; Lumefantrine/therapeutic use ; Malaria, Falciparum/drug therapy ; Phenotype ; Plasmodium falciparum/genetics ; Prospective Studies ; Uganda/epidemiology
    Chemical Substances Antimalarials ; Chloroquine (886U3H6UFF) ; Lumefantrine (F38R0JR742)
    Language English
    Publishing date 2021-06-18
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2666-5247
    ISSN (online) 2666-5247
    DOI 10.1016/s2666-5247(21)00085-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top